Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Ambroxol as a Novel Disease Modifying Treatment for Parkinson's Disease Dementia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02914366
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:56.862279+00:00
Published At
2024-02-28T00:00:00+00:00
Record Updated At
2024-02-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Parkinson\u0027s Disease Dementia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-02-28"
protocolSection.identificationModule.nctId
"NCT02914366"
protocolSection.identificationModule.officialTitle
"Ambroxol as a Novel Disease Modifying Treatment for Parkinson\u0027s Disease Dementia"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Parkinson's Disease Dementia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.